Study Of Asthma In Patients Of African Descent
Study Of Asthma In Patients Of African Descent
This study will last up to 62 weeks. You will visit the clinic up to 17 times. Certain clinic
 visits will include physical examination, medical history review and lung function tests. The
 purpose of this study is to see if one asthma drug (fluticasone propionate/salmeterol) is
 better in reducing the number of asthma exacerbations compared with another drug (fluticasone
 propionate alone)
Inclusion criteria:

 -  History of asthma for at least 6 months.

 -  Taking a low-dose of an inhaled corticosteroid for at least one month prior to the
 study (such as fluticasone propionate or budesonide).

 Exclusion criteria:

 -  History of life-threatening asthma.

 -  Hospitalized for asthma within 3 months prior to the study.

 -  Current respiratory tract infection.

 -  Will not be able to attend clinic visits for the entire length of the study.

 -  Certain medical conditions that will make being in the study unsafe (such as
 congestive heart failure, uncontrolled hypertension, tuberculosis or certain drug
 allergies).